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Preface 
 
 
During the second half of my studies Nutritional Sciences at the University of 
Vienna, I focused on the semi-elective module Nutrition and Environment, which 
amongst other lectures included seminars on nutrition and ecology, food 
production and environmental protection as well as on environmental analysis. To 
further improve and strengthen my knowledge in the fields I was most interested in 
- the impact of food production on the environment and environmental pollutants in 
nutrition - I knew I had to write my diploma thesis in a related field. Fortunately, Dr. 
Hans-Peter Hutter offered me the opportunity to support his work at the Institute of 
Environmental Health of the Medical University Vienna. The topic of my thesis was 
soon settled, it would deal with the mercury burden of the human body including 
the examination of human body tissues.  
 
 
Structuring of the Thesis 
 
The thesis is divided into two main parts, a literature survey on mercury and a 
description of the practical laboratory part and its evaluation.  
The basic information on mercury of the literature part is on one hand based on 
scientific results and findings of specialized books as well as on papers published 
in pubmed.org. On the other hand I also included expert opinions like for example 
the statements of diverse environmental agencies on relevant topics. 
 
Before I could start the practical lab work, the study had to be granted by the 
ethics committee of the Medical University of Vienna. The positive reply was given 
in June, the first sampling eventually started in August 2011. The samples for the 
study were provided by the Institute of Pathology of the Medical University of 
Vienna.  
The laboratory part mainly took place at the Institute for Medical Genetics Vienna, 
where I was permitted to use the lab equipment that was needed to analyse the 
mercury content of human body tissues.  
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Since my advisor at the Institute of Medical Genetics had only worked with blood, 
urine and hair samples before, we had to get proper information on the amount of 
tissue needed for further analysis with Atomic Fluorescence Spectroscopy in the 
first place. Having read several scientific papers on the topic, but none of them 
including explicit information on the exact amount of organ tissue used for 
measuring the samples, we finally managed to get proper information from two 
different working groups after having contacted them via email.  
All in all, I was permitted to obtain a perfectly smooth work flow, which above all 
was brought to an end just in time. 
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I. INTRODUCTION 
 
 
Heavy metals have been used by humans since early ancient times. One of the 
first mentions of mercury was by the Greek philosopher, doctor and naturalist 
Theophrastus (371-287 BC), who described in detail the manufacture of mercury 
by powdering cinnabar with vinegar in pots made of copper. (Vienecke-Janz et al., 
2008)  
The Romans are said to have used the metal as an ingredient in salves to alleviate 
dental pain in children whereas the Greek applied mercury as a cosmetic to lighten 
up the skin. (Järup 2003) 
Throughout the centuries mercury has thus widely been used in industry, 
agriculture and medicine. For example, it has been provided for the treatment of 
the venereal disease syphilis from the 1300s to the late 1800s, which explains the 
origin of the phrase: “Two minutes with Venus, two years with mercury.” (O`Shea 
1990)  
In the 1970s, the organic compound methylmercury was also still used as a 
common fungicide for seed grain. (Järup 2003) 
It was only during the second half of the 20th century that the poisoning effects of 
mercury were specifically analyzed. Earlier discoveries of the toxicity of 
methylmercury, which mostly occurred on workers during production processes, 
have regrettably been overlooked, ignored and disregarded over centuries. (D`ltri 
and D`ltri 1978)  
In 1953, several cases of mercury intoxication emerged in the shore of Minamata 
Bay, Japan. The clinical picture, called the Minamata Disease, was officially 
reported in 1956. (Ekino et al. 2007) Mercury containing waste of the local 
chemical company The Chisso Corporation polluted the bay in the years 1932 to 
1968, contaminating fish and shellfish in the seawater and therefore causing the 
disease in about 3.000 people, who frequently consumed the seafood. Affected 
individuals showed severe neurological deficits, in some cases the poisoning even 
lead to death. (Dobbs 2009)  
Until today a lot of research has been done with regard to mercury and its effects 
on human health. 
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It is now an established fact that the element is a highly toxic heavy metal, which 
accumulates in the environment and which is therefore classified as priority 
hazardous by the EU Water Framework Directive. But despite all research that has 
been done until now, there are several questions left unanswered. Since it is for 
example still not possible to analyze the individual mercury burden of inner human 
body tissues in vivo, the results of this study shall contribute new findings to the 
latest research. 
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II. LITERATURE SURVEY  
 
 
1. Basic Information on Mercury  
 
1.1. Isotopes of Mercury 
There are seven stable main isotopes of mercury in the environment:  
202Hg (29,86%), 200Hg (23,10%), 199Hg (16,84%), 201Hg (13,18%), 198Hg (9,97%), 
204Hg (6,87%) and 196Hg (0,15%) (Gagnon 2011) 
The half-lives of the 27 unstable isotopes vary from seconds up to years. Whereas 
half-life is no longer than one day for the majority of isotopes, it is 444 years in the 
case of 194Hg. 
 
1.2. Physiochemical Properties of Mercury 
Mercury is classified as heavy metal with the atomic number 80. The common 
abbreviation for the element is the symbol Hg, derived from the Greek word 
hydrargyrum (hydr-: watery or runny and –argyros: silver).  
Mercury exists in three forms: elemental mercury, inorganic mercury salts and 
organic mercury compounds. Elemental mercury or metallic mercury is liquid 
under standard temperature and pressure conditions and has a silvery white 
appearance. Because of its strong cohesion, droplets of liquid mercury show high 
surface tension on flat surface. Compared to other metals, the vapor pressure of 
mercury is very high (1.2 × 10-3 torr). It slowly evaporates into the air, forming 
odourless mercury vapor. Melting point of mercury is at -38.84° C, boiling point at 
356.58°C. (Adolph 2007, Ibrahim et al. 2006) As well as every other metal, 
mercury can conduct electricity. 
 
Naturally, there are various chemical compounds in the environment. The 
oxidation states of mercury are Hg0, Hg1+ and Hg2+. Since the element is able to 
build stable compounds with carbons like alkyl, alkoxyalkyl or aryl groups, mercury 
occurs in organometallic forms but also in inorganic forms, as it combines readily 
with halogens and sulphur at room temperature. (Holleman et al. 1995) In 
combination with tin, copper, gold or silver, the element forms alloys, the so-called 
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amalgams. Depending on the composition, the alloys are either liquid, doughy or 
solid. (Kommission Human-Biomonitoring 1999) 
 
 
 
Tab. 2: Reaction of mercury with some common reactants 
Reactant Conditions Reaction products 
Noble gases In discharge tubes HgAr, HgKr 
Halogens At room temperature  
on excess of hal. 
Mercurous halide 
Mercuric halide 
Oxygen, air At about 350°C        
 
HgO (Hg, O2 at 
temp. > 350°C) 
Ozone Room temperature HgO 
S, Se, Te 
Dry Hydrides HX (X = F, Cl) 
H2S, NH3, PH3, AsH3 etc.  
On heating 
> 200°C 
> 200°C 
HgX2 
ICl Room temperature HgCl2, HgI 
NO2 Room temperature Hg2 (NO2)2 
Hg2(NO3) 2 
Conc. H2SO4 Room temperature Hg I, Hg II, sulfates 
HNO3 Room temperature Hg I, Hg II, nitrites, 
nitrates 
Ammonia solution In air Millons base 
 
                                                                                           (Hutzinger 1980) 
Tab. 1: Forms of inorganic and organic mercury 
Inorganic Organic 
Mercuric chloride  
Mercuric iodide 
Mercuric oxide  
Mercuric sulphide  
Mercurous chloride 
Ethylmercury 
Methylmercury 
Merbromin 
Merthiolate 
Phenylmercuric salts 
 
                                                                                    (Neustadt and Pieczenik 2007) 
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1.3. Mercury in the Environment 
Sources of mercury in the environment are manifold. On one hand mercury can be 
found naturally, mainly in mineral form, on the other hand the anthropogenic 
emissions have rapidly increased throughout the last century and are of 
undeniably growing importance.  
 
1.3.1. Natural Sources 
In nature, the element mostly occurs as metallic mercury in mercury sulphide 
(HgS; trivial name: cinnabar). The corrosion of minerals in rocks and soil liberates 
the metal. Due to wind and water erosion mercury is eventually spread into the 
environment. Because of the ability of elemental mercury to form vapor, it can 
enter the atmosphere and thus reach distant regions. Figure 1 illustrates the Hg-
cycle in the environment. 
Other key causes for mercury distribution in nature are volcanic activities, geysers, 
thermal fluids, undersea vents, degassing of the earth mantle, emanation from the 
ocean and forest fires. (Hutzinger 1980) Most of the mercury, which accumulates 
in forest foliage, derives from the atmosphere. Fire releases the metal out of the 
leaves, and then mercury again enters soil and water. (Ericken et al. 2003)  
 
 
Tab. 3: Global mercury emissions by natural sources estimated for 2008 
Source Mercury 
(mg yr−1) 
Contribution 
(%) 
 
Oceans 
 
2682 52 
Lakes 
 
96 2 
Forests 
 
342 7 
Tundra/Grassland/Savannah/Prairie/Chaparral 
 
448 9 
Desert/Metalliferous/Non-vegetated Zones 
 
546 10 
Agricultural areas 
 
128 2 
Evasion after mercury depletion events 
 
200 4 
Biomass burning 
 
675 13 
Volcanoes and geothermal areas 
 
90 2 
Total 
 
5207 100 
               (Pirrone et al. 2010) 
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In 1967 a simple experiment showed, that inorganic mercury salts can be 
transformed into methylmercury by microorganisms. (Jensen and Jernelov 1967) 
This way “(W) methylation of mercury from all sources causes worldwide 
contamination of freshwater fish and seafood by methylmercury” (Grandjean et al. 
2010) 
 
 
 
Fig. 1: Global mercury cycle (Hutzinger 1980) 
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1.3.2. Anthropogenic Sources 
Today about two-thirds of the global mercury pool are considered to be 
anthropogenic. Only one-third derives from natural (geological) sources. (Hurley 
2006)  
Main anthropogenic causes for mercury release into the environment are coal-
burning, caustic soda and cement production, the chlor-alkali industry and the 
disposal of mercury-containing products. It is also still used in gold mining in 
various countries of Latin America. (Järup 2003) 
According to information from the Canadian Government in 2010, 95% of the 
estimated 200.000 tonnes of mercury emitted to the atmosphere since 1890 is 
currently embedded in terrestrial soil stocks or part of the oceanic basin. 
(Environment Canada, 2010). Moreover, remote areas like the Arctic and 
Antarctic, thousands of kilometres away from major anthropogenic sources also 
show significant mercury load, which can be explained by transboundary 
atmospheric long-range transport.  
Even though North America and Europe considerably reduced their mercury 
emissions during the last 30 years, no significant change in the atmospheric pool 
of mercury has been detected. An explanation for this stagnancy can be either the 
increased pollution by other countries (Asia) and/or an unknown compensating 
factor. (Hurley 2006)  
A decrease in the mercury content of the soil in Austria could however be noted. 
This happened most likely due to the existing eco-political measures that were 
devised by the European Union and the Austrian government to reduce the 
national heavy metal emissions and stocks. (Reisinger et al. 2009) 
 
 
 
Fig. 2: Global emissions of 
total Hg from anthropogenic 
sources in the year 2000.  
Total emission: 2269 tonnes  
(Pacyna et al. 2006) 
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Tab. 4: Global mercury emissions from anthropogenic sources 
 
Source category Hg emission 
(mg yr−1) 
 
 
Coal and oil combustion 
 
810  
Non-ferrous metal prod. 
 
310  
Pig iron and steel prod 
 
43  
Cement production 
 
236  
Caustic soda production 
 
163  
Mercury production 
 
50  
Artisanal gold mining prod.  
 
400  
Waste disposal 
 
187  
Coal bed fires 
 
32  
VCM production 
 
24  
Other 
 
65  
Total 2320  
                                                                
                                                                        (Pirrone et al 2010) 
 
 
1.4. Current Data on Mercury in Austria 
National mercury stocks today contain about 47 tonnes of the metal. The main part 
is located in forests. The annual decrease is about 0.2 tonnes. 
About 4 tonnes of mercury are imported annually. 
2 tonnes reach private households every year in the form of amalgam fillings 
(about 1 tonne) and mercury-containing products (batteries, switches, lamps, 
electronic equipment etc.).  
Every year about 10 tonnes of mercury waste accumulate in the form of junk 
goods, residual waste, waste water, and exhaust fumes. Mercury stocks on 
dumpsites add up to about 110 tonnes.  
(Reisinger et al. 2009)  
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2. Use of Mercury in Industry and Medicine 
 
Mercury features some very specific properties that make it a very attractive metal 
for industry and medicine. Its high density (13.5g per cc), its liquid state at room 
temperature and its strong volume expansion due to temperature variations offer 
some unique options in material processing. Moreover, the ability to conduct 
electricity and to form vapor, especially when current is applied, can be used for 
the fabrication of mercury-vapor lamps or fluorescent lights.  
Sectors of industry that use mercury or mercury-containing products during 
manufacturing, are mainly the electrical Industry and the chlor-alkali industry 
where mercury is used as an electrode in the electrochemical process of 
manufacturing chlorine. (Umweltbundesamt 2009) 
 
2.1. Mercury-containing industrial products 
• Batteries (Mercuric Oxide Batteries, Alkaline) 
• Vacuum lamps, energy saving lamps 
• Catalysts 
• Oscillators 
• Detergents and Cleaners 
• Thermometer, manometer, barometer 
• Electrical equipment (conductor plates, cathode ray tubes, switches, relays) 
   (Umweltbundesamt 2009) 
 
2.2. Mercury in medical products 
• Dental amalgam: again the unique properties of mercury - especially the good 
binding capacity with the powdered alloy - make it a favoured ingredient for dental 
fillings. About half of a dental amalgam filling is made of liquid mercury; the other 
part is a powdered alloy of silver, tin, and copper. The role of mercury is to bind the 
composition and create a highly durable and solid filling. (WHO/IPCS 2003) 
During the 1970s, mercury concentrations in some dental surgeries went up to 20 
µg/m3. Today levels have generally decreased to about one-tenth of those 
concentrations. (Järup 2003) 
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Even though dentists use more and more alternative tooth fillings, there are still 
about 18 tonnes of mercury contained in amalgam fillings in Austria today, making 
this the largest mercury stock in private households. (Reisinger et al. 2009) 
 
• Thimerosal is an organomercury compound, containing 49% of ethylmercury 
(CH3-CH2-Hg
+). (Clarkson 2002) The beige-coloured powder is used as a 
preservative in cosmetic and pharmaceutical products in order to prevent them 
from microbial growth during storage and use. It also shows a very efficient 
antiseptic and antifungal effect.  
Today Thimerosal is still contained in vaccination, ophthalmic (cleaning solution for 
contact lenses, eye drops) and nasal products, tattoo inks, antivenoms and 
cosmetic products (make up, make-up remover)  (Schultz 2010) 
 
• Merbromin is a mercury containing dye with antiseptic effect. It is sold as a two-
percent solution (US & FR: Mercurochrome® / DE & CH: Mercuchrome®). In some 
countries, including Austria and Germany, the product is no longer available due to 
its content of mercury. 
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3. Absorption, Metabolism and Elimination in the Human Organism 
 
The absorption ratio of mercury is determined by the form of the metal and its 
route of exposure. Elemental, inorganic and organic mercury each show 
distinctively different effects with regard to human health impairment.  
 
 
3.1. Elemental Mercury 
Poisoning by elemental mercury mainly takes place due to inhalation of the vapor, 
but may also occur due to ingestion of liquid mercury or dermal absorption. More 
than 75% of the mercury vapor stays in the lungs and is well absorbed within the 
organ. (Graebe and Pollack 1998)  
Because of its mono-atomic structure, the mercury-specific high vapor pressure 
and its high lipophilicity, elemental mercury is characterized by a rapid diffusion 
through the alveolar membrane. It thus enters the pulmonary circulation very 
quickly. Animal experiments with mice and monkeys showed that significantly 
more mercury is transported to the brain after inhalation of elemental mercury than 
after intravenous injection of equivalent doses. (WHO/IPCS 2003) The toxic 
element eventually reaches different body tissues and organs via the blood 
circulation. Main targets of mercury accumulation are the central nervous system 
and the kidney.  
Elemental mercury in the intestine is of rather harmless consequences, since it is 
hardly absorbed by the healthy gut (less than 0.1%) and excreted in the feces. 
(Goldmann 2001)  
Cutaneous exposure rarely causes serious physical impairments, because of the 
rather low amount of absorption. Important to mention, however, is the local 
dermal reaction of the skin when mercury reaches the subcutaneous area. 
Elemental mercury as well as inorganic salts have been identified as sensitizing 
agents on the skin of sensitive persons. This is why direct skin contact of the metal 
as well as the contact with mercury containing vaccines or tattoo ink may cause 
extensive contact dermatitis and even distant skin lesions. The causative 
mechanisms of the immune system have not been identified yet.  
In adults, the half-life of elemental mercury is 60 days (range: 35-90 days). 
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The biological half-life is yet different for the different organs. To some extent, 
mercury remains absorbed by the body. In brain and bones it may still be detected 
after years. (Dobbs 2009) The biggest part is excreted in feces (42%) and urine 
(52%), while only a minor part is exhaled. (Reichl 2009, Goldman 2001) 
 
 
3.2. Inorganic Merucry Salts 
Absorption routes of inorganic mercury salts are similar to those of elemental 
mercury, but the toxic effects of the pathways are remarkably different. In case of 
exposure, the intestine shows the highest absorption ratio, followed by the way of 
inhalation and dermal routes. (Ibrahim et al. 2006) Unlike metallic mercury, the 
inorganic salts are well absorbed by the gut and may cause serious corrosion to 
the gut mucosa. (Goldman 2001) As a result, ulceration and perforation in stomach 
and intestine may emerge and hence may lead to an increased absorption of the 
heavy metal. Main target organ of inorganic mercury salts is the kidney, where it 
accumulates in the proximal convoluted tubules. (Graeme and Pollack 1998) The 
biological half-life for inorganic mercury is about 40 days. (Dobbs 2009) Its 
elimination from the human body takes place via the kidneys (60%) as well as the 
feces (40%). (Reichl 2009) 
 
 
3.3. Organic Mercury Compounds 
In terms of organic mercury, humans are basically exposed to two different major 
compounds: methylmercury, which is primarily found in fish and seafood, has to be 
mentioned in the first place. Aside, ethylmercury has also become a widely 
discussed public health concern to humans since it is used as a preservative in a 
number of vaccines for preservation purposes.  
Main difference between the two organic forms is their route of exposure. While 
methylmercury is ingested with food and readily absorbed via the intestine, 
ethylmercury may only be administered by medical injection. Again, primary target 
organ for both forms is the central nervous system.  
Between the day of exposure and the onset of the first symptoms, a latent period 
of weeks or even months may pass by.  
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Both forms share equal properties such as their close chemical affinity and a 
similar initial distribution inside the human body. They also show similarities in the 
type of brain damage at high doses. (Clarkson et al. 2003) 
But one should regard the distinctively different properties as well. As a matter of 
fact, methylmercury is the more potent compound with a longer biological half-life 
of about 50 days. Ethylmercury on the other hand is rapidly metabolized into 
inorganic mercury, which may be the reason why ethylmercury not only affects the 
central nervous system but also causes kidney damage. The biological half-life of 
ethylmercury in blood is 7 to 10 days and therefore much shorter than the half-life 
of methylmercury. (Clarkson et al. 2003) 90% of organic mercury is excreted via 
the feces, while only 10% are excreted via the urine. (Reichl 2009) 
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4. Toxicity 
 
Mercury is biologically not essential and toxic to all organisms. The toxicity 
naturally depends on its chemical form, which determines the specifically different 
properties of the metal. (Dobbs 2009) The organic compound methylmercury is 
believed to be the most toxic form. (Järup 2003) Beyond that, the severity of 
poisoning by the heavy metal depends on additional factors like length and dose of 
exposure, route of absorption as well as gender, age and vulnerability of an 
affected person. (Dobbs 2009) One of the main target organs of mercury in the 
body is the central nervous system. Even though the central nervous system is 
protected by the blood-brain-barrier, the heavy metal gains access without any 
problems, which then leads to a variety of neurological symptoms after mercury 
exposure. (Dobbs 2009) 
Since there is a wide range of possible effects on various body tissues, but no 
disease-specific symptoms, diagnosis and treatment of mercury intoxication turn 
out to be very difficult and treacherous.  
Still, after cessation of exposure symptoms of mercury intoxication are reversible. 
(Järup 2003) 
 
 
4.1. Elemental Mercury 
In 1865, Lewis Carroll introduced the character of the Mad Hatter in his book 
Alice`s Adventures in Wonderland. The cause of Mad Hatter’s insanity was the 
brain disease that oftentimes affected hat makers throughout the 19th century, who 
used liquid mercury to treat their hat felt. (Goldman 2001) This crazy character 
already indicates the hazardous effect mercury may have on human health.  
As mentioned above, the absorption ratio of metallic mercury in the intestine is 
extremely low (less than 0.1%). Yet it may be increased by abnormal gut function 
such as decreased gut motility or fistulae, which restrain the ingested substances 
and thereby lead to prolonged exposure and increased absorption of the toxic 
metal. (Graebe and Pollack 1998)  
Cutaneous reactions due to mercury exposure mainly occur with sensitive 
persons, or in case of high or chronic contact with the metal. Dermal 
manifestations of mercury poisoning may lead to well known clinical syndromes 
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like acrodynia (also known as pink disease), mucocutaneous lymph node 
syndrome, mercury exanthema, cutaneous hyperpigmentation or cutaneous 
granulomas. (Boyd et al. 2000) 
Inhalation of mercury vapor has yet always been of major concern, especially for 
those, who frequently handle the metal during working procedures. The risk of 
serious lung damage increases with the amount of elemental mercury inhaled. 
High acute exposure affects the lung directly and consequently leads to 
inflammation of the bronchia, which may cause dispnoea and cyanosis. 
(Umweltbundesamt Fact Sheet) Extreme acute exposure may even result in acute 
necrotizing bronchitis and pneumonitis, which in some cases lead to death from 
respiratory failure. (Goldman 2001) On a cellular level, mercury interferes with a 
number of different metabolic processes, including protein phosphorylation, protein 
and nucleic acid synthesis, calcium homeostasis and oxidative stress. (Ibrahim et 
al. 2006).  
Early nonspecific signs include insomnia, forgetfulness, loss of appetite, and mild 
tremor, which is often misdiagnosed as psychiatric illness. Chronic intake may lead 
to the classic triad of progressive tremor, gingivitis and erethism, a syndrome 
characterized by red palms, emotional lability, and memory impairment. (Clarkson 
1997) Salivation, excessive sweating, and hemoconcentration are accompanying 
signs of the autonomic nervous system. Mercury also accumulates in kidney 
tissues, directly causing renal toxicity, including proteinuria or nephrotic syndrome. 
Isolated renal effects may also be immunologic in origin. (Goldman 2001)  
 
 
4.2. Inorganic Mercury Salts 
Absorption of mercury salts in the gut may cause serious corrosion to the gut 
mucosa, which thereupon may result in gastrointestinal ulceration or perforation 
and hemorrhage. In many cases, this progression ends in circulatory collapse. 
(Goldman 2001) 
Further effects of the breakdown of the intestinal mucosa barriers are extensive 
mercury absorption and transport to the kidneys, where the inorganic salts show 
their very toxic properties. Proteinuria, hematuria, glycosuria, oliguria, uremia, 
immunologic glomerulonephritis and acute renal failure are common 
consequences of acute inorganic mercury intoxication. Renal tubular acidosis and 
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nephrotic syndrome are symptoms of chronic absorption. (Graebe and Pollack 
1998) Central neuropathy and acrodynia may also occur from mercury salt 
exposure. (Goldman 2001) 
Another alarming presumption has emerged during the last decade, concerning 
the exposure of inorganic mercury compounds and the potentially correlated 
increased incidence of Alzheimer`s disease (AD). In 2007, a German research 
group stated: 
 
The available data does not answer the question, whether mercury is 
a relevant risk factor in AD distinctively. In sum, the findings from 
epidemiological and demographical studies, the frequency of 
amalgam application in industrialized countries, clinical studies, 
experimental studies and the dental state of Alzheimer patients in 
comparison to controls suggest a decisive role for inorganic mercury 
in the etiology of Alzheimer's disease. Other factors currently 
discussed as causes (e. g. other metals, inflammations, dietetic 
factors, vitamin deficiency, oxidative distress, and metabolic 
impairments) may act as co-factors.  
  (Mutter et al. 2007) 
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4.3. Organic Mercury Compounds 
Main source of methylmercury exposure for humans today is the consumption of 
fish and seafood. Organic forms of mercury are well absorbed within in the 
intestine and since it acts as a potent neurotoxine, it primarily affects the central 
nervous system, evoking severe health impairments. (Clarkson T.W. 1997) 
In 1940, four cases of methylmercury intoxication were reported by Hunter, 
Bomford and Russel. The poisioning accrued due to fungicidal dusts at a working 
place, causing symptoms such as dysarthria, ataxia, constriction of the visual field 
and eventually causing death in the worst cases. The characteristic symptoms of 
mercury vapor poisoning, however, were not reported. Only the occurrence of 
tremors resembled the well-known symptoms of mercury vapor intoxication.  
The autopsy of the deceased patients showed that the symptoms led back to 
atrophies of different brain tissues, amongst others the cerebellar cortical and 
bilateral cortical tissues. (Satoh 2000) 
Later examinations of the brain revealed regional destructions of neurons in the 
visual cortex and cerebellar granule cells, involving paresthesias of the circumoral 
area and hand and feet as well as visual-field constriction and ataxia. (Clarkson et 
al. 2003) 
 
Besides, the toxic properties of ethylmercury, the major component of thimerosal, 
have become a subject of concern for publicity during the last twenty years. 
Especially in terms of the significant increase in the diagnosis of autism and 
Alzheimer`s Disease throughout the last decades, ethylmercury was taken into 
consideration as a cause of the diseases.  
It is indeed noticeable that the prevalence of autism increased from 5 in 10.000 to 
60 in 10.000 in the United States in the early 1990s. Possible explanation for this 
scenario could have been the implementation of three additional thimerosal-
containing vaccines for newborn babies during that time. (Mutter et al. 2005) 
Studies focusing on the correlation of mercury exposure and the occurrence of 
autism are contradictory.  
Holmes et al. concluded in 2003 that the metabolism of autistic people appeared 
to show a deficient efficiency in terms of mercury excretion. Results attested that 
the severity of the disease was inversely related to hair mercury levels. Even 
though the mothers of the autistic babies showed significantly higher levels of 
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mercury exposure, mainly due to Rho D immunoglobulin injections and amalgam 
fillings, the mean value of mercury concentrations of the hair in autistic babies was 
0.47 ppm, while the mean value of the control group was 3.63 ppm. 
There was as well no correlation between hair mercury levels and the mercury 
exposure of the mothers. In the control group, however, mercury levels of the hair 
were significantly correlated to their mother`s mercury exposure. (Holmes et al. 
2003) 
According to the results of this study, autistic babies were proven to have a 
malfunctioning of their bodies` mercury excretion. Whether this dysfunction also 
causes or increases the risk for the neurodevelopmental disorder is still not entirely 
analyzed. 
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5. Human Exposure  
 
Because of the great variety of mercury sources in our environment, mercury 
intake is inevitable for almost everyone in modern society today. The metal is 
actually omnipresent and can be found in inorganic and organic form in food and 
as an additive in vaccines. Moreover, a large mercury stock exists in the mouths of 
most people due to the implementation of amalgam fillings for dental restoration. 
Main sources of mercury exposure are listed in the following. 
 
 
5.1. Fish and Seafood 
Because of its numerous nutritional benefits, fish is proclaimed to be part of a 
healthy and well-balanced diet. Especially the low amount of saturated fatty acids 
and high amount of vitamin D and essential omega-3 polyunsaturated fatty acids 
make fish an important component in human nutrition. In spite of these beneficial 
values, the highly toxic substance methylmercury has also become a hot topic in 
terms of fish and seafood 
Because of its lipophilic properties, mercury is characterized by a high degree of 
bioaccumulation. Phyto- and Zooplankton concentrate both inorganic and 
alkylated mercury, which subsequently enters the food chain efficiently. (Hutzinger 
1980) Therefore comparably high amounts of the metal can be found in animals, 
especially in the tissues of aquatic animals. Since the mercury burden of marine 
waters has remarkably increased throughout the last century, more and more 
mercury residues can be found in fish and seafood. The mercury levels naturally 
increase with size and age of the animal. Highest mercury contents can be found 
in predators such as pike and bass in freshwater and swordfish and shark in the 
oceans. (Clarkson et al. 2003) These species may even show a biological 
magnification of up to 100.000 times from the algae level. (Ahrenholt-Bindsley 
1992) The chemical form of mercury in biological tissues like fish is the organic 
form methylmercury. The basic concentration of mercury in unpolluted sea water 
has been reported to be at least 0.1 ng per litre. (Fowler 1990) Geological and 
atmospheric mercury sources provide an additional natural input of the metal and 
therefore contribute to an annual increase of mercury concentrations in marine 
waters of about 100.000 tonnes. Although anthropogenic sources still represent a 
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minor part of the total mercury input, it may be the cause for serious environmental 
pollution in restricted domains like inland waters or coastal waters. (Kruse and 
Bartelt 2008) Near the industrial areas of New York Harbor, the water contained up 
to 90 ng per litre of dissolved mercury concentrations in 1990. (Fowler 1990)  
 
In 2006, the Eighth International Conference on Mercury as a Global Pollutant took 
place in Madison, Wisconsin, USA. With regard to methylmercury in fish, the 
Conference Organizing Committee recommends: 
 
Fish can contain both methylmercury and beneficial omega-3 fatty acids. 
Methylmercury exerts toxicity and can also diminish the beneficial health 
effects of omega-3 fatty acids. As with mercury, there are large variations 
in the level of omega-3 fatty acids in fish. Selection of fish species for 
consumption should seek to maximize the intake of beneficial fatty acids 
while limiting exposure to methylmercury.  
                                                             (Hurley and Krabbenhoft 2006) 
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5.2. Tooth Fillings  
In 1926, the German chemist Alfred Stock described a curious disease, which 
moderately started with slight symptoms but over the years became much worse. 
In the end, the suffering was almost unbearable. It was his own condition, Stock 
specified in his article The Hazards of Mercury Vapor. He suffered from chronic 
mercury intoxication for over 25 years. Eventually, he was one of the first to 
identify mercury as source of the disorders and also one of the first to describe the 
symptoms of mercury poisoning. With regard to dental tooth fillings, which were 
used since the early 1920s, Stock concluded: It will then turn out to be likely that 
the reckless implementation of amalgams as tooth fillings was a fatal sin against 
humanity. (Stock 1926) 
Amalgam has been the material of choice for the restoration of broken teeth 
throughout the whole last century. The contained metals of an amalgam filling 
vary, but mercury has always been a steady component, because of its ability to 
bind the other powdered alloys. The content of the heavy metal quite often 
reaches 50%. (Clarkson 2002) Today, more and more dentists use alternative 
tooth fillings, like ceramic, gold or synthetic material. With the exception of the 
Scandinavian countries, the usage of mercury containing amalgams is yet not 
forbidden and still common in some dental procedures. 
Even though a lot of research on this topic has been done over the past 30 years, 
results are still controversially discussed today. Several studies proved the release 
of mercury vapor out of amalgam fillings. (Ott et al. 1984, Vimy and Lorscheider 
1985, Nylander et al. 1987, Aronsson et al. 1989, Marek 1992, Molin 1992, 
Björkman et al. 2007) A research group from New Zealand examined 172 people 
with regard to their amalgam fillings and found out that the mercury vapor 
concentration in the exhaled breath was high enough to be of chronic toxicologic 
hazard for some of the examined people. (Patterson et al. 1985)  
The amount of mercury released depends on several additional factors: quality, 
composition and number of fillings, intensity and length of chewing, eating habits 
(hot, acidic) and ratio of mouth to nose breathing. (Kommission Human-
Biomonitoring des Umweltbundesamtes 1999, Ferracane et al. 1995) 
Breath takes the evaporated mercury into the lungs, where a big part enters the 
pulmonary circulation. A minor amount of vapor reaches the human intestine and 
is absorbed there. Via both routes of absorption, mercury eventually reaches 
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different body tissues and organs through blood circulation. In 2007, a research 
group from Norway discovered a significant correlation between the number of 
dental amalgam surfaces and the concentrations of inorganic mercury in blood and 
brain of 30 deceased people at the time of death. (Björkman et al. 2007) 
Amalgam fillings thus permanently release small amounts of the toxic heavy metal. 
Average daily intake of elemental mercury from dental amalgams for an average 
person is about 3.8-21 µg. These amounts are yet not associated with an 
increased health risk. (IPCS 1990) A high number of amalgam fillings, optionally 
together with mercury intakes from additional sources, may nevertheless lead to 
chronic poisoning of the human body in the long term. (Clarkson 2002) 
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5.3. Vaccination 
Thimerosal (TMS) is the most widely added preservative in more than 50 licensed 
vaccines. The most common thimerosal-containing vaccine is hepatitis B. (Egan 
1999) As mentioned above, thimerosal contains up to 49.55% ethylmercury, which 
is bound to the thiol group of a salicylic acid. It was developed in 1927 and still 
today, there is not much information about the effects of ethylmercury (CH3-CH2-
Hg+) on human health, although it is assumed that its toxicity is similar to 
methylmercury (CH3-Hg
+), which is a chemically very close compound. (Clarkson 
2002) This is why TMS-containing vaccines are suggested to cause severe 
neurological impairments like autism or attention deficit hyperactivity disorder 
(ADHD), especially when administered to children during early stages of 
development. (Stratton et al. 2001) 
Even though there are differences in route of administration, magnitude of doses 
and pharmacokinetics for ethylmercury, limits for intake are based on those for 
methylmercury. (Egan 1999) 
Like on amalgam, different opinions exist on the harmlessness of thimerosal, 
although there have been several studies that tested and oftentimes confirmed 
thimerosal toxicity for many decades now. (Nelson 1966, Heyworth 1982, Royhans 
et al. 1984, Digar et al. 1987, Nascimento et al. 1990, Hilleman 1991, Lowell et al. 
1996) 
If the thimerosal compound (ethylmercury – salicylic acid) was stable, it could 
rapidly be transported to the kidney and lastly be excreted via the urine. 
Unfortunately, a breakdown to ethylmercury hydroxide and thiosalicylate may 
occur, after dissolution of the compound and reaction of the mercury radical with 
the hydroxyl ions of the thimerosal solution. The ethylmercury breakdown product 
is considered to be responsible for thimerosal toxicity, because of its high 
reactivity. (Geier et al. 2007)  
In 1999, Egan outlined the evidence of thimerosal toxicity in a presentation to the 
FDA. According to the review, the contained ethylmercury may lead to local 
hypersensitivity reactions and show acute toxicity at high doses (including coma 
and death). For children, one of the most vulnerable groups, the paper 
recommended: “Infant exposure to mercury from vaccines may be largely 
avoidable by using thimerosalfree products.” (Egan 1999) Today thimerosal has 
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been removed from all vaccines on the recommended childhood immunization 
schedule for children younger than seven years. (Stratton et al. 2001)  
Even though the review left some very important unanswered questions (“Is 
ethylmercury toxicity the same as methylmercury?”), there has been no further 
research to provide new approaches.  
In 2001, Magos wrote a review on ethylmercury toxicity, that summarized all 
known cases of human intoxication and evaluated the entire published data, but 
information remained the same and there is still insufficient scientific evidence that 
developmental neurotoxicity could result from thimerosal exposure. (Magos 2001) 
The same year, the Immunization Safety Review Committee of the National 
Academy of Sciences Institute of Medicine wrote: 
 
The committee concludes that although the hypothesis that exposure to 
thimerosal-containing vaccines could be associated with 
neurodevelopmental disorders is not established and rests on indirect and 
incomplete information, primarily from analogies with methylmercury and 
levels of maximum mercury exposure from vaccines given in children, the 
hypothesis is biologically plausible. 
The committee also concludes that the evidence is inadequate to accept 
or reject a causal relationship between thimerosal exposures from 
childhood vaccines and the neurodevelopmental disorders of autism, 
ADHD, and speech or language delay. 
  (Stratton et al. 2001) 
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5.4. Mercury Exposure of the Fetus and the Breast-Fed Infant  
In the early 1970s, Iraqi farmers disseminated mercury-treated seed grain onto 
their fields. The consumption of home-made bread, baked of the contaminated 
grain, led to a series of methylmercury intoxications in the local population. It is 
suggested that almost 1000 people were affected, while only 370 were 
hospitalized. (Bakir et al. 1973) A number of clinical observations of that time 
allows an immerged insight into the effects and consequences of methylmercury 
poisoning, particularly on newborn babies and children. A survey of children, 
whose mothers were exposed to methylmercury during pregnancy, showed that 
methylmercury readily passes from mother to fetus. The study also indicates that 
the poisoning may result in physical impairment of the offspring, since six out of 15 
babies showed clinical manifestations of mercury poisoning, five of them 
exceedingly severe with impaired motor and mental development. (Amin-Zaki et al. 
1974) 
Since the metal reaches the child via the umbilical cord, the fetus is exposed to 
methylmercury as well as inorganic mercury throughout the whole pregnancy. 
Based on the analysis of data from the Minamata disease, Sakamoto et al. 
discovered an important coherence of prenatal mercury exposure and an unequal 
sensitivity of the male and female sex in 2001. It seems that male fetuses were 
more susceptible to mercury intoxication as they showed a higher stillbirths ratio 
than their female counterparts. (Sakamoto et al. 2001) Animal experiments on 
mice also proved the higher sensitivity of male fetuses on mercury exposure. The 
administration of methylmercury led to significant neurobehavioral effects, 
particularly in the development of male mice. (Yoshida et al. 2011) Results of 
diverse animal experiments suggest that pre- and postnatal mercury exposure 
may hence affect the brain functions of the fetus. (Newland et al. 1996) It would, 
however, need further studies to prove the influence of prenatal mercury exposure 
and faulty fetal development. 
The transmission of mercury from mother to child is yet undeniable and has been 
proven in many surveys over the years. 
In 2001 a Swedish research group screened the mercury levels of the blood of 20 
Swedish women before and after they gave birth. After childbirth, they also 
checked up on the blood mercury levels of the babies. Aside from giving blood 
samples, the women had to fill out a questionnaire about their fish consumption, 
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vaccination and dental care during the preceding 6 months and 13 weeks after 
childbirth. Results showed that methylmercury (MeHg) concentrations of the 
maternal blood strongly correlated with the concentrations of MeHg in cord blood 
and infant blood at 4 days, although the cord and infant blood levels were two 
times higher than those of maternal blood. 
Maternal methylmercury increased from childbirth to 13 weeks postpartum, 
whereas methylmercury concentrations of the children declined from 4 days to 13 
weeks after birth. (Björnberg et al. 2005)  
The decrease of the infant blood levels during the breast-feeding period can be 
explained by the low mercury transfer through breast milk and the rapid growth of 
infants after birth. (Sakamoto et al. 2002) 
Surprisingly, fish consumption had no influence on the mercury levels of maternal 
or infant blood, nor did dental care during pregnancy and breast-feeding period 
result in higher concentrations in the blood of the women. 
Not surprising, however, was the significant correlation between the number of 
amalgam surfaces with the concentrations of inorganic mercury (I-Hg) in the 
maternal blood. 
The values of I-Hg did not show any change before and after the women gave 
birth to their babies, the infant blood I-Hg levels correlated with those of their 
mother and decreased until 13 weeks of age. (Björnberg et al. 2005) 
 
There is only vague information on the exposure to MeHg and I-Hg in breast-fed 
infants. Animal studies suggest that both MeHg and I-Hg are transported from 
blood plasma to breast milk primarily bound to serum albumin, with I-Hg also 
bound to casein. (Sundberg et al. 1999) No significant correlation was found 
between MeHg in the blood of the mother and mercury in breast milk. (Björnberg 
et al. 2005)  
 
In summary, the resulting implication of the research findings can only be that, in 
order to protect the unborn child from possible negative health effects of mercury 
intoxication, exposure routes and mercury intake of the mother need to be 
minimized as much as possible. 
To detect the mostly very subtle effects arising from prenatal exposure such as 
cognitive changes and delayed development in children is surely still a difficult task 
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and a huge challenge for researchers and medical scientists today. In their review 
of 2011, Greandjean and Herz summarized the complexity of the topic as follows: 
 
The outcome of developmental neurotoxicity may not be immediately 
apparent in the infant, but deficits will become evident later on as long-
standing or irreversible dysfunctions. More generally, the delayed 
recognition of developmental neurotoxicity due to methylmercury heralds 
some limitations in scientific documentation that may lead to deficient 
prevention of neurotoxic exposures.  
  (Greandjean and Herz 2011) 
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5.5. Energy Saving Lamps 
In April 2009, the European Union published the regulation (EG) 244/2009, which 
determines the efficiency of regular lamps for household usage. Since commonly 
used bulbs did no longer achieve the newly regulated values, they have been 
completely replaced by so-called energy saving lamps (ESL). According to the 
information on the homepage of the European Commissioner for Energy Günther 
Oettinger, the durability of ESL is six to ten times higher whereas their current 
consumption is 75-80% lower than those of common bulbs. The change of lamps 
is supposed to save enough energy to supply eleven million households until 
2020. (European Union 1995-2011)  
Moreover, the usage of the ESL is said to reduce anthropogenic mercury 
emissions. Due to the application of regular household lamps 2.7 tonnes of 
mercury emissions accrued in 2007, because of the high power requirement (coal-
burning) and the mercury-containing compact fluorescent lamps that were not 
recycled at the end of life. In 2020 emissions may increase up to 3.1 tonnes if no 
countermeasures are applied. Even though an ESL contains mercury as well, the 
allowed content and the current needed to run it are both lower, so that mercury 
emissions will significantly decrease. (Piebalgs 2009) Although this scenario is 
based on assumptions, it has become a very popular argument for proponents of 
the ESL and is by now commonly known as the mercury-paradox.  
Current limit for the mercury content in ESL is 5 mg per lamp. For lamps with a 
power capacity of less than 50 watt, the limit will be reduced to 3.5 mg in January 
2012. Maximum permissible values for lamps with a capacity lower than 30 watt 
will be 2.5 mg mercury per lamp starting January 2013. (Piebalgs 2009) Lowest 
mercury content in an ESL of today is about 1 mg. (Umweltbundesamt 2010) 
 
The arguments for ESL seem convincing, nevertheless critical voices surfaced 
within the past three years. On one hand the health risks due to the mercury 
content of ESL have been reviewed, on the other hand the promoted advantages 
of the new bulbs have been inspected and the results of both objections are quite 
notable. 
The first study on energy saving lamps and their potential health risk due to 
mercury emissions was initiated at the Maine Institute of Environmental Protection 
in 2008. Research interest was to measure the mercury concentrations after the 
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breakage of an ESL. Results showed significantly increased values of mercury in 
the surrounding air. Peak values were 50 – 100 µg/m3. (Stahler et al. 2008) These 
results triggered great concern and demanded awareness, especially for 
vulnerable groups (children, pregnant women), which may get in contact with 
mercury emissions at these high values. Households including risk groups shall 
therefore always take precaution by using ESL with plastic coating.  
Based on these results, the German Federal Environmental Agency also tested 
mercury emissions from broken ESL. Peak values exceeded the allowed value of 
0.35µg/m3 twenty times. (Umweltbundesamt 2010) 
This is why in 2010 the German umbrella organisation Verbraucherzentrale 
Bundesverband demanded to defer the decided ban of regular lamps in 
households. 
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III. HUMAN BIOMONITORING 
 
 
1. Background and Objective 
 
Human Biomonitoring was initially designed for the monitoring of certain 
occupational groups, which were particularly exposed to pollutants at work. Today 
it is also used as a screening-method for the analysis of internal exposure to 
pollution in humans. Main objective of the examination is to determine substances 
(mainly pollutants) that are able to enter the human organism as well as the 
amount of those substances, which are consequently stored in different body 
tissues. Therefore it is necessary to examine different body samples, like fluids 
(blood, urine, breast milk) or tissues (hair, muscle/adipose tissue). Subsequently 
the substances and their metabolites are detected by various chemical and / or 
technical methods. Since Human Biomonitoring does not indicate the ratios of the 
substances in the target organs, the obtained material is called indicator media or 
surrogate marker. (Umweltbundesamt GmbH, 2011) (Reichl and Schwenk 2004) 
The definition for Human Biomonitoring of the The European Environment & 
Health Action Plan 2004-2010, was adopted by the European Commission as 
“monitoring activities in human beings, using biomarkers, that focus on 
environmental exposures, diseases and/or disorders and genetic susceptibility, 
and their potential relationships". (Joas and Polcher 2009) 
 
The method can be divided into two types of monitoring: 
- Human biological monitoring of exposure: systematic examination  
 (once or repeated) of certain substances and their metabolites from  
 various body samples (blood, serum, breast milk, urine, teeth, hair) 
-  Biological effect monitoring: systematic examination (once or  
 repeated) of biological parameters, which result from the exposure to  
 chemical, physical or biological substances and which thus show a  
 certain effect. 
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2. Scopes and Limits of Human Biomonitoring 
 
- Scopes can be mainly differentiated into three domains: 
1.  Examination of a single person, who is exposed to a certain  
 substance or who is assumed to be exposed to a certain substance 
2.  A quantitative examination of the pollutant exposure of a certain  
 group of people or a certain population group during an  
 epidemiological study 
3.  Examinations to detect specific trends in terms of pollutant exposure  
 of humankind  
 
- Limits of the human biomonitoring : 
1.  Human Biomonitoring can not differentiate between the different ways  
 of entry or the sources of pollution. Therefore it is crucial to get  
 additional information about the person’s living habits.  
2.  This method can not be used for the analysis of pollutants, which  
 already affect external and / or internal mucous membranes or  
 pollutants, and are only absorbed in very small amounts. 
3.  Pollutants with short dwell time in the human organism can only be  
 detected in a particular time period after absorption. 
4.  The exposure of substances, which occur or are excreted naturally in  
 the human body, is usually not detectable. 
5. There is not necessarily a correlation between the amount of  
 pollutants in the indicator media and the amount of pollutants in the  
 target organs.    
  (Kommission Human Biomonitoring 1996) 
 
Overall human biomonitoring is an important method for evaluating internal 
pollutant exposure in human organisms as well as its effects on human health. 
Many environmental pollutants can thus be detected. 
The method is already used in several countries to gather information on the 
human pollution level on an individual and national level. Moreover it can be used 
as an instrument for the promotion of health and environmental protection and to 
verify the effectiveness of political strategies and interactions.  
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IV. RESEARCH INTEREST 
 
 
Recent research identified the main target organs of mercury and already showed 
correlations between mercury levels of different body tissues like blood and brain 
and between the number of amalgams in teeth and the mercury levels in blood. 
(Björkman et al. 2007) In 1995, Cernichiari et al. already demonstrated a strong 
correlation between the mercury content of maternal scalp hair, at the time of 
childbirth, to the mercury content in the brain tissues of the newborn babies. 
(Cernichiari et al. 1995) Moreover, Zareba et al. stated in 2008: 
 
[W] hair levels are more likely to reflect brain levels as the mechanisms of 
uptake by the hair follicle very likely involve the same transport 
mechanisms that operate across the blood-brain barrier. 
 (Zareba et al. 2008) 
 
These approaches were mainly the origins of the considerations for this thesis. 
Since the mercury burden of different human body tissues in living organisms is – 
except for hair – still not measurable today, we thought of analyzing human body 
tissues, whose mercury contents are well-established by now. 
Aim of this study was the analysis of a correlation of the Hg-content of the hair and 
the Hg-content of inner organs (brain, kidney) to improve the understanding of the 
consequences of chronic mercury exposure in the human body.  
Therefore, the Hg-contents of different human body tissues were analysed and 
subsequently compared to one another in order to detect possibly existing 
correlations of the values and in order to screen the potential indicator function of 
the hair with regard to the Hg-values of the inner organs. 
Primary hypothesis of the study is hence to infer that the mercury content of the 
hair gives evidence for the mercury contents of inner organs. 
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V. MATERIALS AND METHODS 
 
 
1. Specimen 
 
The samples used for the examination of mercury in different human body tissues 
were descended from ten corpses that were provided by the Clinical Institute of 
Pathology at the AKH/MUW Vienna. Further handling of the samples was carried 
out at a laboratory of the Institute for Environmental Health, Centre for Public 
Health of the Medical University of Vienna. The Hg-content of the samples was 
eventually determined at the Institute of Medical Genetics of the Medical University 
of Vienna by Atomic Fluorescence Spectroscopy (AFS) technique. 
 
 
1.1. Sampling 
Samples were taken from five female and five male corpses at the age of 22 to 70 
at the time of death. Bodies that showed any trait of iatrogenic mercury 
contamination or mercury contamination caused by force (e.g. an accident) were 
excluded from further examination. 
In order to detect a correlation of different tissues, two samples per body were 
taken out of the brain (hypothalamus, corpus callosum) and the kidney (renal lobe, 
renal capsule) and were then put in a jar made of polycarbonate (Nalgene 
Labware).  
To compare the Hg-content of the inner organs with the content of hair, a strand of 
hair was removed from each corpse. Hair strands were cut off in the occipital 
region using ceramic scissors in order to avoid metallic contamination. If long 
enough, the final hair sample included a three centimeter segment of hair closest 
to the scalp. (Gundacker 2007) 
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Tab. 5: Description of the specimen 
Female Proband Code Year of Birth Amalgam Fillings 
F01  874 1956 7 
F02  892 1958 ---* 
F03  968 1944 ---* 
F04  1040 1950 0 
F05  1043 1988 ---* 
    
Male Proband Code Year of Birth Amalgam Fillings 
M01  920 1958 3 
M02  1937 1953 ---* 
M03  941 1940 ---* 
M04  973 1947 ---* 
M05  1065 1952 ---* 
* amalgam fillings could not be noted due to rigor mortis  
 
 
Fig. 3: Collected tissue samples of brain and kidney 
 
 
 
Left: cross section of hypothalamus (red) and corpus callosum (blue) 
Right: cross section of renal lobe (blue), renal capsule (red) 
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1.2. Sample Transport 
Immediately after the sampling, the tissues were transported to a laboratory at the 
Institute of Medical Health, where they were put into a freezer at -21 °C. Hair 
samples were collected in regular envelopes, which were stored at room 
temperature.  
As the sample collection of all ten probands was completed, the frozen tissues 
were put into cooled bags and then were conveyed to the Institute of Medical 
Genetics for further handling. 
 
 
1.3. Sample Preparation 
 
In the beginning, the defrosted tissue samples were cut into tiny pieces with a 
ceramic knife while the hair samples were rinsed with deionized water. After that, 
precisely 0,5g of each tissue as well as 
the cleaned hair samples (3cm) were 
digested with a mixture of 2mL 65 
vol.%HNO3 (Merck, Suprapur) and 
0.75 mL 30% H2O2 (Merck, p.a.) in 
pressurized Teflon vessels in a 
microwave digestion unit for 40 
minutes. After cooling down, the 
digested solutions were transferred to 
20-mL volumetric flasks. The vessel 
was rinsed with 5 mL deionized water, 
which was then added to the solution. 
Finally the flask was filled up to 20 mL 
with deionized water. (Gundacker et al. 
2007) 
 
 
 
 
 
 
                Fig. 4: Non-metallic lab tools  
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Fig. 5: Microwave digestion of the processed samples 
  
Carrier of the microwave vessels Microwave MERCK mls 1200 mega 
 
 
Fig. 6: Examples of tissue samples  
 
left renal lobe 
left: renal capsule 
right: hypothalamus  
right: corpus callosum 
left renal lobe 
left: renal capsule 
right: hypothalamus  
right: corpus callosum 
 
 
 
 
 
 
 
  
 
samples of proband F01 samples of proband M04 
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2. Quantitative Determination of Mercury Levels in Brain, Kidney 
and Hair by Atomic Fluorescence Spectroscopy (AFS) 
 
2.1. Principle of Mercury Determination with AFS 
The process of the AFS technique can be divided into two main parts:  
 
 
1. Atomization  
A gas flow carries the vapor into heated regions where the sample molecules turn 
into ground state atoms. A hollow-cathode-lamp or a laser emits a beam of light 
into the atomic vapor, which excites the atoms.  
 
2. Detection 
The decay of the atoms of the excited electronic state results in the emission of 
photons and therefore in fluorescent light, whose single wavelengths can be 
selected by a monochromator. The detector then reads and amplifies the signal. 
 
 (Tissue B.M.1999) 
 
 
Fig. 7: Transitions between molecular electronic  
energy levels (The University of Adelaide 2011) 
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By adding a reducing agent to the sample solutions, the appearance of gases, 
which might have a quenching effect on mercury fluorescence, is minimized. The 
bottle with the reducing agent (SnCl2) is connected to the apparatus before starting 
the analysis. Carrying gas for mercury in the AFS Mercur Plus is the inert gas 
Argon. (Analytik Jena AG 2007) 
A low-pressure mercury lamp emits radiance at 253.7nm, which is exactly the 
range at which mercury atoms absorb light. Before the light strikes the sample 
solution in the cuvette, it has to pass a lens made of quartz crystal, which 
optimizes radiance efficiency. When coming to the cuvette, fluorescent radiation is 
deflected at a 90° angle and then again passes a biconvex quartz lens. The light is 
channelled and reproduced on a UV-sensitive photomultiplier. (Analytik Jena AG 
2007) 
 
 
 
1. low pressure mercury   
    lamp 
2. quartz lens 
3. cuvette 
4. quartz lens 
5. receiver 
Fig. 8: Optics scheme of AFS Mercur Plus (Analytik Jena AG 2007) 
 
Main reason for mounting the source lamp for atomic fluorescence at an angle to 
the rest of the optical system is that the light detector only captures the 
fluorescence radiation this way and not the light from the lamp itself. (Analytik Jena 
AG 2007) 
Because of the rather low background of the fluorescence signal, atomic 
fluorescence technique provides high measuring sensitivity. Besides, AFS allows 
an extremely precise analysis with a detection of values as low as ppm and even 
ppt. 
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2.2. Measuring Instruments and Settings 
Mercury concentrations were determined by atomic fluorescence technique, using 
the AFS Mercur Plus (Analytik Jena AG) apparatus. Quality assurance was 
achieved by measuring blank test solutions and reference material (Seronorm 
Trace Elements Whole Blood, LOT 1003192). The reference material was 
prepared in the beginning and after each tenth sample preparation and was 
therefore all in all measured six times, in order to assure that no impreciseness 
occurred during the whole preparation process.  
All metal contents were measured in triplicate by the working curve method. The 
limit of detection (LOD) was determined by the concentration equivalent to the 
threefold standard deviation of the signal of the blank solution (0.0024µg/kg). 
(Gundacker et al. 2007) 
 
 
Fig. 9: AFS Mercur 
Plus 
 
 
2.3. Experimental Procedure 
After sample preparation, it was necessary to prepare a set of standard solutions, 
in order to get a straight line to which the sample results could be related. 
Standard solutions emanated from a concentrated mercury stock solution (MERCK 
Certipur: Hg(NO3)2 in HNO3, 2mol/L), which was used to make 100ml of a 100bbp 
solution. This Hg-solution was blended as follows: 
 
Standard1:  2ml conc. HNO3  
Standard 2:  2ml conc. HNO3 + 400µl Hg-solution 
Standard 3:  2ml conc. HNO3 + 800 µl Hg-solution 
Standard 4:  2ml conc. HNO3 + 1200 µl Hg-solution 
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Standard 5:  2ml conc. HNO3 + 1600 µl Hg-solution 
Standard 6:  2ml conc. HNO3 + 2000 µl Hg-solution 
All standard solutions were filled up to 20ml with deionized water. Before starting 
the analysis, a bottle of HCl and a bottle filled with the reducing agent SnCl2 were 
connected to the apparatus. 
 
After that, all samples were filled into glass 
vessels, which belonged to the Mercur Plus 
and were then put into the measuring 
apparatus. Measuring was accomplished 
using a test record.  
(see attachment: 2. Test Record) 
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VI. DATA ANALYSIS 
 
 
1. Description of the Obtained Material 
The analysis of the different human body tissues showed following results: 
 
 
 
 
 
  
   Straight line for all  
  six standard  
  solutions 
 
 
 
 
 
 
 
 
 
 
  Straight line for  
  standard solutions  
  0, 1 and 2  
  (more precise) 
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*Target range: 13.6-16.8, mean 15.2 
 
Tab. 7: Hg-content of the female body tissues in µg/kg (ppb)  
 F01 F02 F03 F04 F05 
Hair 50.75 4.64 11.52 5.87 46.60 
Corpus Callosum 0.07 0.07 0.62* ---* 0.46 
Hypothalamus 4.88 ---* ---* 0.09 2.33 
Renal Lobe 97.94 1.28 0.10 5.81 9.26 
Renal Capsule ---* ---* ---* ---* ---* 
* test result below LOD 
 
Tab. 8: Hg-content of the male body tissues in µg/kg (ppb) 
 M01 M02 M03 M04 M05 
Hair 7.34 17.48 7.31 46.26 108.11 
Corpus Callosum ---* 0.17 ---* ---* ---* 
Hypothalamus 0.43 0.20 ---* 0,40 1.44 
Renal Lobe 1.03 ---** 2.29 1.24 0.51 
Renal Capsule ---* ---** ---* ---* ---* 
* test result below LOD 
** no kidney tissue available due to organ donation 
 
 
Tab. 9: Mean Hg-content of the different tissues in µg/kg (ppb) (± sd) 
 H CC HT RL 
Total  30.588 ± 33.03 0,077 ± 0.146 4.937 ± 11.78 11.946 ± 30.357 
Women 23.876 ± 22.834 0.12 ± 0.193 1.46 ± 2.156 22.878 ± 42.12 
Men 37.3 ± 42.673 0.034 ± 0.076 8.414 ± 17.666 1.014 ± 0.860 
 
 
H  = hair 
CC  = corpus callosum 
HT  = hypothalamus 
RL  = Renal Lobe 
Tab. 6: Hg-content of the reference material in µg/kg (ppb) 
1 2 3 4 5 6 Mean* 
13.5 12.2 12.7 13.9 12.7 13.5 13.1 
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2. Statistical Analysis of the Mercury Content of Different Body Tissues 
 
 
2.1. Kolmogorov-Smirnov Test 
 
Kolmogorov-Smirnov-Test 
 hair cc hypothalamus kidney 
N 10 10 10 9 
Mean 30.5880 .0770 4.9370 13.2733 Parameter of normalitya,b 
Standard Deviation 33.03228 .14568 12.41777 31.89017 
Absolute .254 .319 .402 .439 
Positive .254 .319 .402 .439 
Most extreme differences 
Negative -.216 -.299 -.345 -.340 
Kolmogorov-Smirnov-Z .804 1.009 1.271 1.317 
Asymptotic Significance (2-tailed) .538 .260 .079 .062 
a. normally distrubted. 
b. calculated from the data. 
 
Extreme differences that are bigger than 0.409 (n=10) or 0.43 (n=9) are not 
normally distributed (P = 0.05). In this case, kidney values are not normally 
distributed. 
 
 
2.2. Spearman`s Rank Correlation Coefficient 
 
Since kidney data are not normally distributed and since the sample size is rather 
low, correlation dimensions were calculated with the non-parametric Spearman`s 
rank correlation coefficient. 
 
Formula for Spearman`s rank correlation coefficient 
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Coefficient values are determined at a range between -1 for an absolute negative 
correlation and +1 for an absolute positive correlation. A Spearman`s correlation 
coefficient of 0 means, that there is no linear relationship between the two 
compared parameters.  
 
Tab. 6: Classification of Spearman`s correlation coefficients 
 
0 no correlation 
0 – 0.2 very weak correlation 
0.2-0.5 weak correlation 
0.5 – 0.7 middle-sized correlation 
0.7 – 0.9 strong correlation 
> 0.9 very strong correlation 
  
 
 
2.2.1 Correlation of the Hg-Levels of Hair and Brain 
 
Correlations 
 hair hypothalamus 
Correlation Coefficient 1.000 .767** 
Sig. (2-tailed) . .010 
hair 
N 10 10 
Correlation Coefficient .767** 1.000 
Sig. (2-tailed) .010 . 
Spearman-Rho 
hypothalamus 
N 10 10 
**. Correlation is significant at the 0.01 level (2-tailed). 
 
 
Correlations 
 hair cc 
Correlation Coefficient 1.000 .206 
Sig. (2-tailed) . .569 
hair 
N 10 10 
Correlation Coefficient .206 1.000 
Sig. (2-tailed) .569 . 
Spearman-Rho 
cc 
N 10 10 
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Evaluation of the data resulted in a positive Spearman`s correlation coefficient of 
0.767 for hypothalamus and hair and a coefficient of 0.206 for corpus callosum 
and hair. 
This means a strong positive correlation between hypothalamus and hair, which 
was statistically significant (rs = .767, p = 0.01).  
Corpus callosum and hair, however, shows no measurable correlation. 
 
 
2.2.2. Correlation of the Hg-Levels of Hair and Kidney 
 
Correlations 
 hair kidney 
Correlation Coefficient 1.000 -.017 
Sig. (2-tailed) . .966 
hair 
N 10 9 
Correlation Coeficient -.017 1.000 
Sig. (2-tailed) .966 . 
Spearman-Rho 
kidney 
N 9 9 
 
Spearman correlation coefficient for renal lobe and hair is -0.17 (p=0.966), marking 
a non-existing correlation of the two parameters. 
 
 
2.2.3. Correlation of the Hg-Levels of Corpus Callosum and Hypothalamus 
 
Correlations 
 cc hypothalamus 
Correlation Coefficient 1.000 .187 
Sig. (2-tailed) . .604 
cc 
N 10 10 
Correlation Coefficient .187 1.000 
Sig. (2-tailed) .604 . 
Spearman-Rho 
hypothalamus 
N 10 10 
 
With a Spearman`s rank correlation coefficient of 0.187 and p=0.604, no 
correlation exists between corpus callosum and hypothalamus. 
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2.2.4. Correlation of the Hg-Levels of Corpus Callosum and Kidney 
 
Correlations 
 cc kidney 
Correlation Coefficient 1.000 .647 
Sig. (2-tailed) . .059 
cc 
N 10 9 
Correlation Coefficient .647 1.000 
Sig. (2-tailed) .059 . 
Spearman-Rho 
kidney 
N 9 9 
 
The p-value of the two parameters corpus callosum and kidney is bigger than 0.05, 
indicating a non-existing correlation. 
 
 
2.2.5. Correlations of the Hg-Levels of Hypothalamus and Kidney 
 
Correlations 
 hypothalamus kidney 
Correlation Coefficient 1.000 .305 
Sig. (2-tailed) . .425 
hypothalamus 
N 10 9 
Correlation Coefficient .305 1.000 
Sig. (2-tailed) .425 . 
Spearman-Rho 
kidney 
N 9 9 
 
Correlation coefficient between hypothalamus and kidney is 0.305 (p=0.425), 
which also results in a non-correlation of the two parameters. 
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VII. DISCUSSION 
 
 
Aim of this study was to analyse different human body tissues, in order to detect a 
correlation between the mercury concentrations of hair and those of the examined 
inner organs. 
The evaluated Spearman`s correlation coefficients were strongly significant in only 
one of the six calculated cases. The correlation between hair and hypothalamus 
(rs=0.767, P=0.01) showed a significant result.  
As mentioned above, it has already been stated by Zareba et al., that hair mercury 
levels may reflect the mercury levels of the brain since transport mechanisms of 
mercury into the hair follicle resemble the transport mechanism of mercury, 
passing the blood-brain barrier. Therefore our findings would affirm the results of 
this study with regard to the correlation between hair and hypothalamus. (Zareba 
et al. 2008)  
 
Furthermore, it would be advisable, to not only analyse the whole mercury 
concentrations, but to distinguish between anorganic mercury salts and organic 
methylmercury. This would increase the information value in terms of these 
different mercury forms and their behaviour in human body tissues, since this 
study only proves correlations between the whole Hg-contents of the human body 
but can not provide more specific information on correlations of methylmercury or 
anorganic mercury in different organs. 
Such an analysis requests another specific analytical apparatus, the mass 
spectrometry. This analysis can be performed at The National Environmental 
Agency in Vienna. A continuative step after having finished this study will therefore 
probably be the more differentiated analysis of the different chemical mercury 
forms, in order to get more information on the different ways of mercury distribution 
in the human body.  
All in all, it has to be said, that the sample size of this study was rather low, so that 
our findings may only indicate a tendency towards reality. Further research has to 
be done to clarify the remaining questions. 
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VIII. CONCLUSION 
 
 
During the last sixty years it has clearly been proven that the exposure to mercury, 
regardless to its chemical form, affects the human body directly, which make it a 
serious threat for human health.  
Even though it is positive to mention that most dentists abandoned mercury-
containing amalgam fillings out of their surgeries and that even the application of 
thimerosal in vaccines is regarded critically by now, it is still not possible to avoid 
exposure completely, since there are various sources of the metal in the 
environment. 
The mercury burden in the population is distinctively individual and therefore 
significantly varying. It is thus very unfortunate that there is still no possibility to 
diagnose the individual mercury burden. But it is also clear that no in vivo-analysis 
may be performed on the target organs of mercury - brain and kidney. 
This is why mercury intoxication mostly remains undetected, especially low chronic 
intake with no clinically apparent symptoms, or, even worse, is misdiagnosed, for 
example as the symptoms of mental stress. 
Aim of this project was to provide a new approach with regard to mercury 
distribution in human body compartments and with regard to possible existing 
correlations between the mercury content of the hair and the mercury content of 
the inner organs. Evaluation of the analyzed tissue samples, however, showed 
that such a correlation does not exist in most cases. Only the correlation between 
hair and hypothalamus was strong enough to be considered significant. 
Aside, we confirmed that despite the lipophilic properties of methylmercury, no 
evidence of mercury accumulation was found in renal capsule tissue. 
An individual rate of Hg-excretion or variable performances of the different 
chemical mercury forms in the body may be an explanation for the results of this 
study, but only a more differentiated analysis might ensure these assumptions.  
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Abstract 
 
 
Studien der letzten sechzig Jahre haben eindeutig erwiesen, dass eine 
Quecksilberexposition, unabhängig von der chemischen Form des Schwermetalls, 
negative Auswirkungen auf die menschliche Gesundheit hat.  
Obwohl die großflächige Anwendung quecksilberhaltiger Zahnfüllungen reduziert 
wurde und auch Thimerosal in Impfungen bereits als kritisch betrachtet wird, ist es 
nahezu unmöglich, eine Aufnahme von Quecksilber zu vermeiden. Abhängig von 
der individuellen Ernährungs- und Lebensweise, ist jeder Mensch verschiedenen 
Quecksilberquellen unterschiedlich häufig und intensiv ausgesetzt. Die daraus 
resultierende individuelle Quecksilberbelastung kann bis heute nicht durch 
diagnostische Verfahren nachgewiesen werden. Eine in-vivo-Analyse der 
Zielorgane Gehirn und Niere ist jedenfalls nicht möglich. Eine Vergiftung durch 
Quecksilber bleibt daher meist unentdeckt, vor allem wenn es sich dabei um eine 
geringe chronische Aufnahme ohne klinisch manifeste Symptomatik handelt. 
Häufig kommt es auch zu Fehldiagnosen, wie zum Beispiel Belastungsstress. 
Ziel dieser Biomonitoring-Untersuchung war der Nachweis einer Korrelation des 
Hg-Gehaltes von Haaren mit den Hg-Gehalten von Hirn- und Nierengewebe zur 
Verbesserung des Verständnisses von Nachweisen einer chronischen Hg-
Belastung im menschlichen Körper. Die Auswertung der Ergebnisse zeigte 
allerdings, dass eine derartige Korrelation nur in einem der untersuchten Fälle 
stark genug war, um als signifikant angesehen zu werden. Eine Erklärung dafür 
kann die individuelle Ausscheidungsrate von Quecksilber im menschlichen 
Organismus oder aber die unterschiedlichen Verhaltensweisen der verschiedenen 
chemischen Formen von Quecksilber im Körper sein. Eine Überprüfung dieser 
Vermutungen kann jedoch nur durch weitere Untersuchungen erfolgen. 
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Abstract 
 
 
During the last sixty years it has clearly been proven that the exposure to mercury, 
regardless to its chemical form, affects the human body directly, which make it a 
serious threat for human health.  
Even though it is positive to mention that most dentists abandoned mercury-
containing amalgam fillings out of their surgeries and that even the application of 
thimerosal in vaccines is regarded critically by now, it is still not possible to avoid 
exposure completely, since there are various sources of the metal in the 
environment. 
The mercury burden in the population is distinctively individual and therefore 
significantly varying. It is thus very unfortunate that there is still no possibility to 
diagnose the individual mercury burden. But it is also clear that no in vivo-analysis 
may be performed on the target organs of mercury - brain and kidney. 
This is why mercury intoxication mostly remains undetected, especially low chronic 
intake with no clinically apparent symptoms, or, even worse, is misdiagnosed, for 
example as the symptoms of mental stress. 
Aim of this project was to provide a new approach with regard to mercury 
distribution in human body compartments and with regard to possible existing 
correlations between the mercury content of the hair and the mercury content of 
inner organs. Evaluation of the analyzed tissue samples, however, showed that 
such a correlation does not exist in most cases. Only the correlation between hair 
and hypothalamus was strong enough to be considered significant. 
An individual rate of Hg-excretion or variable performances of the different 
chemical mercury forms in the body may be an explanation for the results of this 
study, but only a more differentiated analysis might ensure these assumptions.  
 
 85 
Curriculum Vitae – Simone Spangler 
 
 
Contact Data 
 
St.-Andreas-Str.5 
92331 Parsberg  
Germany 
 
Email: sw8515@gmx.net 
 
 
Personal Data  
 
Date of Birth  5th of March 1985 
 
Place of Birth  Regensburg  
 
Nationality German 
 
 
Education and Training  
 
Since Oct 2005   Studies of the Master`s Degree Programme        
 Science of Nutrition at the University of Vienna, Austria  
 
1995 – 2004  Secondary School Parsberg, Germany 
 
 
Graduation University-Entrance Diploma 
 
 
Internships 
   
08th Feb – 05th Mar 10  University Hospital of Pediatrics Vienna, Austria 
 Head Laboratory and Laboratory for Metabolic Diseases 
 Administration: Univ.-Prof. Dr. Kurt Herkner 
 
15th Jul – 15nd Oct 09 Institute of Medical Microbiology and Hygiene 
 University Hospital Regensburg, Germany  
 Project: Cytomegaly-Virus, Project-Leader: Dr. Michael  
 Nevels 
 86 
 
07th Feb – 14th Mar 07 Seidl Confiserie GmbH Laaber, Germany 
 Domain: Quality Assurance, Packaging, Fabrication 
 
 
Further Occupations 
 
since 15th Oct. 2010  Tutor at the Institute for Hygiene und Applied Immunology,  
 Vienna 
 Administration: Ao.Univ.-Prof. Dipl.-Ing. Dr. Mohammad  
 Manafi 
 
15th Jul  2010 –  Student research assistant at the Institute of Medical  
15th Oct 2010   Microbiology and Hygiene, University Hospital Regensburg,  
 Germany; Project: Cytomegaly-Virus 
 Project-Leader: Dr. Michael Nevels 
  
01st Sept 2008 –   Seidl Confiserie GmbH Laaber, Germany 
28th Sept 2008  Domain: Fabrication                                                                 
 
 
Additional Skills 
 
Language skills German  –  First language 
 English  –  TOEFL IBT 108 credits  
 French  –  DELF A2 
 Swedish  –  Basic knowledge 
 
Workshop  Basics about Communication and Coaching 
 
Honorary post Assistant at the Friede Institute Vienna  
 Center for Dialogue and Integration  
 
 
 
